NCT05384483View on ClinicalTrials.gov

Cariprazine Versus Placebo for Social Anxiety Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

April 4, 2024

Study Completion Date

April 15, 2024

Conditions

Social Anxiety Disorder

Interventions

DRUG

Cariprazine

Cariprazine 1.5 to 3 mg per day

DRUG

Placebo

Matching placebo

Trial Locations (1)

10128

The Medical Research Network, LLC, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

The Medical Research Network

OTHER